AUL
UTHR icon

AlphaGrep UK Ltd’s United Therapeutics UTHR Stock Holding History

AlphaGrep UK Ltd’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$278K Buy
+469
New +$234K 0.08% 551

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

AlphaGrep UK Ltd's UTHR Position: Q1 2026 in Review

AlphaGrep UK Ltd opened a new position in United Therapeutics (UTHR) in Q1 2026: 469 shares worth $278K. The stake represents 0.08% of the portfolio and ranks #551 among its holdings.

853 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • AlphaGrep UK Ltd held 469 shares of United Therapeutics worth $278K as of Q1 2026.
  • United Therapeutics was a new AlphaGrep UK Ltd position in Q1 2026.
  • United Therapeutics made up 0.08% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #551 holding.
  • 853 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.